Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bridging the gap: key evidence needed to strengthen global policies to end TB.
Gebreselassie N, Falzon D, Zignol M, Viney K, Ismail N, Mirzayev F, Mavhunga F, Kasaeva T. Gebreselassie N, et al. Among authors: kasaeva t. Int J Tuberc Lung Dis. 2022 Aug 1;26(8):704-707. doi: 10.5588/ijtld.22.0153. Int J Tuberc Lung Dis. 2022. PMID: 35898130 No abstract available.
Tuberculosis research and development: seeding the future.
Lienhardt C, Zumla A, Gebreselassie N, Frick M, Gray G, Kasaeva T, Raviglione M. Lienhardt C, et al. Among authors: kasaeva t. Lancet Respir Med. 2018 Apr;6(4):242-244. doi: 10.1016/S2213-2600(18)30050-X. Lancet Respir Med. 2018. PMID: 29595503 Free article. No abstract available.
Priorities for global political momentum to end TB: a critical point in time.
Kasaeva T, Baddeley A, Floyd K, Jaramillo E, Lienhardt C, Nishikiori N, Weil DE, Weyer K, Zignol M. Kasaeva T, et al. BMJ Glob Health. 2018 Mar 23;3(2):e000830. doi: 10.1136/bmjgh-2018-000830. eCollection 2018. BMJ Glob Health. 2018. PMID: 29607106 Free PMC article. No abstract available.
Advances in clinical trial design: Weaving tomorrow's TB treatments.
Lienhardt C, Nunn A, Chaisson R, Vernon AA, Zignol M, Nahid P, Delaporte E, Kasaeva T. Lienhardt C, et al. Among authors: kasaeva t. PLoS Med. 2020 Feb 27;17(2):e1003059. doi: 10.1371/journal.pmed.1003059. eCollection 2020 Feb. PLoS Med. 2020. PMID: 32106220 Free PMC article. Review.
The case for assessing the full value of new tuberculosis vaccines.
Gebreselassie N, Hutubessy R, Vekemans J, den Boon S, Kasaeva T, Zignol M. Gebreselassie N, et al. Among authors: kasaeva t. Eur Respir J. 2020 Mar 20;55(3):1902414. doi: 10.1183/13993003.02414-2019. Print 2020 Mar. Eur Respir J. 2020. PMID: 32198269 Free article. No abstract available.
A global strategy for tuberculosis research and innovation.
Gebreselassie N, Kasaeva T, Zignol M. Gebreselassie N, et al. Among authors: kasaeva t. Eur Respir J. 2020 Nov 12;56(5):2003539. doi: 10.1183/13993003.03539-2020. Print 2020 Nov. Eur Respir J. 2020. PMID: 33184100 Free article. No abstract available.
37 results